Mar 22 | Sep 21 | Mar 21 | Sep 20 | Mar 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 727.94M | € 589.94M | € 644.68M | € 300.10M | € 191.00M |
Total Assets | € 1.99B | € 1.67B | € 1.57B | € 1.10B | € 1.00B |
Total Debt | € 557.88M | € 618.36M | € 638.80M | € 291.58M | € 240.90M |
Net Debt | € -170.06M | € 28.42M | € -5.88M | € -8.52M | € 49.90M |
Total Liabilities | - | - | - | - | - |
Stockholders Equity | € 1.04B | € 765.18M | € 676.70M | € 576.54M | € 551.73M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |